$CW

Curtiss-Wright (CW) Q2 2026 Earnings Call Transcript

Curtiss-Wright (CW) reported Q2 2026 adjusted diluted EPS of $3.72, up 15% year over year, on total sales of $924 million, up 5%. New orders were $1.1 billion, up 8%, with a 1.16x book-to-bill. Management raised full-year sales guidance to 8% to 9% and adjusted EPS to $15.10 to $15.40, and lifted free cash flow guidance to $585 million to $605 million.

Original reporting
Published Aug 13, 2026, 7:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Curtiss-Wright (CW) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$CWBullishHigh
01

Why it matters

The key tradable update is the combination of raised full-year sales, EPS, and free cash flow guidance, alongside a stated sequential decline in Q3 operating income and margin.

02

Market read

Traders can reprice CW on the raised 2026 guidance and FCF outlook, while monitoring the flagged Q3 margin normalization risk.

03

What to watch

Supply-chain pressure on rare earth materials and compounds could reintroduce cost or delivery risk, and the article notes Q3 operating income and margin are expected down sequentially.

Relevance 9/10Novelty 9/10Timing: pre-market today, earnings call transcript with raised 2026 guidance

Background

Curtiss-Wright reported Q2 2026 adjusted metrics and used the call to update full-year guidance, emphasizing defense electronics growth and nuclear-related capacity expansion.

Company-level read

Ticker impact

$CWBullishHigh confidence
Context

Curtiss-Wright raised full-year 2026 sales guidance to 8% to 9% and lifted EPS to $15.10 to $15.40 after Q2 results.

Expected impact

Bias toward upward repricing on guidance, with near-term caution for Q3 margin normalization.

Evidence & confidence

The article provides specific, time-relevant guidance changes (sales, EPS, FCF) plus a concrete offset (Q3 operating income and margin expected down sequentially).

Market effects

Supports a constructive read-through for defense electronics and nuclear-adjacent industrial demand, while highlighting supply-chain constraints in surface treatment materials.

US defense and allied procurement demand remains a key driver for US industrial primes and suppliers.

Nuclear capacity expansion themes (AP1000 and related long-lead equipment) reinforce global nuclear supply-chain investment expectations.

Counterpoint

The raised full-year numbers may be partially offset by near-term margin headwinds as mix normalizes and R&D ramps, limiting upside follow-through.

Key entities

  • Curtiss-Wright

    US defense and industrial manufacturer reporting Q2 2026 results and raising full-year 2026 guidance.

  • Lynn Bamford

    CEO, cited defense electronics order strength and expectations for an AP1000 order this year.

  • K. Christopher Farkas

    CFO, discussed sequential Q3 margin pressure and supply-chain constraints.

Related articles

$CWMedAI 8/10

DOE Backs X-Energy Texas Reactor Project With $1 Billion Support

The U.S. Department of Energy (DOE) allocated up to $1 billion to support X-Energy's advanced nuclear reactor project in Texas. Funds will primarily support domestic supply chain partners like Curtiss-Wright, Mirion Technologies, and Fluor. The Range Nuclear Renaissance Index ETF (NUKZ) offers investors exposure to these companies.

$CWMed

Curtiss-Wright Expands 2026 Share Repurchase Authorization

Curtiss-Wright (CW) said it expanded its 2026 share repurchase authorization by adding a Rule 10b5-1 plan that allocates an additional $100 million for buybacks. The company expects total 2026 repurchases of $160 million and said $390 million remains authorized. It plans broker purchases up to Rule 10b-18 limits until the $100 million is deployed, expected by late August 2026.

$CWHighAI 9/10

Curtiss-Wright Q2 Earnings Call Highlights

Curtiss-Wright (NYSE:CW) reported Q2 commentary from its earnings call, citing a strengthening order book tied to U.S. and international defense spending and momentum in commercial aerospace and industrial markets. Defense Electronics sales fell 3% while Aerospace & Industrial and Naval & Power rose. The company raised 2026 guidance: sales +8% to +9%, operating margin 19.1% to 19.3%, diluted EPS $15.10 to $15.40, and record free cash flow $585M to $605M.

$CWMed

Curtiss-Wright Slides as Investors Weigh Strong Q2 Against Rich Expectations

Curtiss-Wright (CW) shares fell about 3.2% as investors weighed a strong Q2 against expectations. The company reported Q2 2026 sales of $924 million (+5%), adjusted operating margin of 19.4%, and adjusted EPS of $3.72, while raising full-year guidance to sales growth of 8% to 9% and adjusted EPS of $15.10 to $15.40. Orders were $1.1 billion (1.16 book-to-bill), but Defense Electronics revenue declined and Ground Defense fell 8% due to timing.

$CWHigh

CURTISS WRIGHT CORP (CW): Results of Operations and Financial Condition

CURTISS WRIGHT CORP (CW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991_cwxq226xearnings.htm EX-99.1 Document Curtiss-Wright Corporation, Page 1 Exhibit 99.1 NEWS RELEASE CURTISS-WRIGHT REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE DAVIDSON, N.C. – August 5, 2026 – Curtiss-Wright Corporation (NYSE: C